1. Combined strategies for tumor immunotherapy with nanoparticles

   • K. Savitsky
   • X. Yu

   Review Article 04 May 2019 Pages: 1441 - 1449

   

2. Central nervous system ependymoma: clinical implications of the new molecular classification, treatment guidelines and controversial issues

   • P. D. Delgado-López
   • E. M. Corrales-García
   • J. Martín-Alonso

   Review Article 13 March 2019 Pages: 1450 - 1463

   

3. Consensus on the use of immune-related response criteria to evaluate the efficacy of immunotherapy in non-small cell lung cancer

   • M. Provencio
   • E. Carcereny
   • Á. Artal

   Research Article 22 March 2019 Pages: 1464 - 1471

   

4. Applying Data Science methods and tools to unveil healthcare use of lung cancer patients in a teaching hospital in Spain

   • J. L. Cruz-Bermúdez
   • C. Parejo
   • M. Provencio

   Research Article 12 March 2019 Pages: 1472 - 1481

   

5. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma

   • J.-W. Feng
   • X.-H. Yang
   • Z. Qu

   Research Article 16 March 2019 Pages: 1482 - 1491

   

6. Skin and lung toxicity in synchronous bilateral breast cancer treated with volumetric-modulated arc radiotherapy: a mono-institutional experience

   • M. Valli
   • S. Cima
   • A. Richetti

   Research Article 14 March 2019 Pages: 1492 - 1498

   

7. Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis

   • Y. Wang
   • J. Zhang
   • Y. Zhao

   Research Article Open access 22 March 2019 Pages: 1499 - 1509

   

8. Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer

   • O. Köstek
   • N. C. Demircan
   • B. Erdoğan

   Research Article 28 March 2019 Pages: 1510 - 1517

   

9. Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib

   • A. Gökyer
   • A. Küçükarda
   • B. Erdoğan

   Research Article 13 March 2019 Pages: 1518 - 1523

   

10. Clinical characteristics and prognosis of different primary tumor location in colorectal cancer: a population-based cohort study

    • C. Zheng
    • F. Jiang
    • S. Li

    Research Article Open access 14 March 2019 Pages: 1524 - 1531

    

11. Macroscopic locoregional relapse from prostate cancer: which role for salvage radiotherapy?

    • A. Bruni
    • G. Ingrosso
    • E. Mazzeo

    Research Article 13 March 2019 Pages: 1532 - 1537

12. Association of neurologic manifestations and CEA levels with the diagnosis of brain metastases in lung cancer patients

    • B. Cacho-Díaz
    • H. Spínola-Maroño
    • O. Arrieta

    Research Article 22 March 2019 Pages: 1538 - 1542

13. Comparison of efficacy of HCAG and FLAG re-induction chemotherapy in acute myeloid leukemia patients of low- and intermediate-risk groups

    • J. Y. Zhang
    • K. Yu
    • L. J. Li

    Research Article Open access 26 March 2019 Pages: 1543 - 1550

    

14. Neural stem cells promote glioblastoma formation in nude mice

    • J. Wang
    • J. Liu
    • X. Yu

    Research Article 03 April 2019 Pages: 1551 - 1560

    

15. Role of multi-modality functional imaging in differentiation between benign and malignant thyroid ¹⁸F-fluorodeoxyglucose incidentaloma

    • H. Shi
    • Z. Yuan
    • X. Ye

    Research Article 29 March 2019 Pages: 1561 - 1567

    

16. Effectiveness of fentanyl pectin nasal citrate in controlling episodes of breakthrough cancer pain triggered by routine radiotherapy procedures

    • J. Pardo
    • A. Mena
    • M. Vidal

    Research Article 15 May 2019 Pages: 1568 - 1572

    

17. Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years’ experience of a reference centre in Spain

    • B. Castelo
    • D. Viñal
    • R. de Lucas

    Brief Research Article 12 March 2019 Pages: 1573 - 1577

    

18. Interplay between neural stem cells and glioblastoma: possible role of neurotrophin signaling

    • R. Roesler

    Correspondence 30 September 2019 Pages: 1578 - 1579

19. Correction to: BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines

    • M. Cuadros
    • V. Sánchez-Martín
    • P. P. Medina

    Correction 26 July 2019 Pages: 1580 - 1580

20. Expression of Concern: BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines

    • M. Cuadros
    • V. Sánchez-Martín
    • P. P. Medina

    Expression of Concern 26 July 2019 Pages: 1581 - 1581